Genomic and metabolomic insights into the natural product biosynthetic diversity of a feral-hog-associated Brevibacillus laterosporus strain

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Theodore, Christine M ^a   Stamps, Blake W ^a   King, Jarrod B ^a   Price, Lauren S L ^a   Powell, Douglas R ^a   Stevenson, Bradley S ^a   Cichewicz, Robert H ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 METHYLTETRADECANOIC ACID; 2,5 BIS(3 INDOLYLMETHYL)PYRAZINE; AURIPORCINE; AURIPYRAZINE; BASILISKAMIDE A; BASILISKAMIDE B; PHENYLALANINE; PROLINE; UNCLASSIFIED DRUG; BIOLOGICAL PRODUCT;

ARTICLE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM ISOLATE; BREVIBACILLUS LATEROSPORUS; CHEMICAL STRUCTURE; CULTURE MEDIUM; DNA EXTRACTION; ELECTROSPRAY MASS SPECTROMETRY; EPIMERIZATION; GENE CLUSTER; GENE SEQUENCE; GENETIC VARIABILITY; GENOMICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; METABOLOMICS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEW SPECIES; NONHUMAN; PHENOTYPE; PHYLOGENY; PROTON NUCLEAR MAGNETIC RESONANCE; SYMBIOSIS; X RAY ANALYSIS; ANIMAL; BACTERIAL GENE; BREVIBACILLUS; CLASSIFICATION; GENETICS; GENOME; METABOLISM; MICROBIOLOGY; SWINE; WILD ANIMAL;

ANIMALS; ANIMALS, WILD; BIOLOGICAL PRODUCTS; BREVIBACILLUS; GENES, BACTERIAL; GENOME; METABOLOMICS; PHYLOGENY; SWINE;

EID: 84896921617     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090124     Document Type: Article

References (29)

1. Newman DJ, Cragg GM (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75: 311-335.
2. Clardy J, Walsh C (2004) Lessons from natural molecules. Nature 432: 829-837. (Pubitemid 40037138)
3. Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, et al. (2008) Evolution of mammals and their gut microbes. Science 320: 1647-1651. (Pubitemid 351931256)
4. Ley RE, Lozupone CA, Hamady M, Knight R, Gordon JI (2008) Worlds within worlds: evolution of the vertebrate gut microbiota. Nat Rev Micro 6: 776-788.
5. Cho I, Blaser MJ (2012) The human microbiome: at the interface of health and disease. Nat Rev Genet 13: 260-270.
6. Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature 486: 207-214.
7. Li K, Bihan M, Yooseph S, Methé BA (2012) Analyses of the microbial diversity across the human microbiome. PLoS ONE 7: e32118.
8. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, et al. (2012) Human gut microbiome viewed across age and geography. Nature 486: 222-227.
9. Piel J (2004) Metabolites from symbiotic bacteria. Nat Prod Rep 21: 519-538.
10. Piel J (2009) Metabolites from symbiotic bacteria. Nat Prod Rep 26: 338-362.
11. Yang JY, Karr JR, Watrous JD, Dorrestein PC (2011) Integrating '-omics' and natural product discovery platforms to investigate metabolic exchange in microbiomes. Curr Opin Chem Biol 15: 79-87.
12. Asensio C, Pérez-Díaz JC, Martínez MC, Baquero F (1976) A new family of low molecular weight antibiotics from enterobacteria. Biochem Biophys Res Commun 69: 7-14.
13. Ruas-Madiedo P, Medrano M, Salazar N, De Los Reyes-Gavilan CG, Perez PF, et al. (2010) Exopolysaccharides produced by Lactobacillus and Bifidobacterium strains abrogate in vitro the cytotoxic effect of bacterial toxins on eukaryotic cells. J Appl Microbiol 109: 2079-2086.
14. Joyner PM, Liu J, Zhang Z, Merritt J, Qi F, et al. (2010) Mutanobactin A from the human oral pathogen Streptococcus mutans is a cross-kingdom regulator of the yeast-mycelium transition. Org Biomol Chem 8: 5486-5489.
15. Wang X, Du L, You J, King JB, Cichewicz RH (2012) Fungal biofilm inhibitors from a human oral microbiome-derived bacterium. Org Biomol Chem 10: 2044-2050.
16. Wei MQ, Mengesha A, Good D, Anné J (2008) Bacterial targeted tumour therapy - dawn of a new era. Cancer Lett 259: 16-27. (Pubitemid 350245421)
17. Jessup DA (2003) Opportunistic research and sampling combined with fish and wildlife management actions or cisis response. ILAR Journal 44: 277-285.
18. Blin K, Medema MH, Kazempour D, Fischbach MA, Breitling R, et al. (2013) antiSMASH 2.0 - a versatile platform for genome mining of secondary metabolite producers. Nucleic Acids Res 41: W204-W212.
19. Barsby T, Kelly MT, Andersen RJ (2002) Tupuseleiamides and basiliskamides, new acyldipeptides and antifungal polyketides produced in culture by a Bacillus laterosporus isolate obtained from a tropical marine habitat. J Nat Prod 65: 1447-1451. (Pubitemid 35239631)
20. Kelly MTS, Anderson RJV, Barsby TAV (2005) Antifungal and antimycobacterial basiliskamides. Patent application US 20050277779.
21. Kitahara T, Aono S, Mori K (1995) Synthesis of both the enantiomers of aseanostatin P5 (sarcinic acid), an inhibitor of myeloperoxidase release, and four diastereomers of aggreceride A, a platelet aggregation inhibitor. Biosci Biotechnol Biochem 59: 78-82.
22. Bythell BJ, Maître P, Paizs B (2010) Cyclization and rearrangement reactions of an fragment ions of protonated peptides. J Am Chem Soc 132: 14766-14779.
23. Kochhar S, Mouratou B, Christen P (2002) Amino acid analysis by precolumn derivatization with 1-fluoro-2,4-dinitrophenyl-5-L-alanine amide (Marfey's reagent). In: Walker JM editor. The Protein Protocols Handbook: Humana Press. pp. 995-1000.
24. Jensen K, Niederkrüger H, Zimmermann K, Vagstad Anna L, Moldenhauer J, et al. (2012) Polyketide proofreading by an acyltransferase-like enzyme. Chem Biol 19: 329-339.
25. Piel J (2010) Biosynthesis of polyketides by trans-AT polyketide synthases. Nat Prod Rep 27: 996-1047.
26. Dyda F, Klein DC, Hickman AB (2000) GCN5-related N-acetyltransferaces: a structural overview. Annu Rev Biophys Biomol Struct 29: 81-103.
27. Cragg GM, Newman DJ (2002) Chemical diversity: a function of biodiversity. Trends Pharmacol Sci 23: 404-405.
28. Bhushan R, Brückner H (2004) Marfey's reagent for chiral amino acid analysis: a review. Amino Acids 27: 231-247. (Pubitemid 40110064)
29. Shaaban M, Maskey RP, Wagner-Dobler I, Laatsch H (2002) Pharacine, a natural p-cyclophane and other indole derivatives from Cytophaga sp. strain AM13.1. J Nat Prod 65: 1660-1663. (Pubitemid 35386798)